MolGraph
CompoundsDocumentationComplianceAbout
MolGraph

Research chemical sourcing and molecular building block RFQ workflows.

MolGraph is operated by Tessorix Inc.

support@molgraph.com

Products are intended for laboratory research use only and are not for human or veterinary use.

Compounds

  • Compound catalog
  • CAS Search

Company

  • About
  • Contact

Documentation

  • Quality Documentation
  • SDS Disclaimer

Compliance

  • Compliance

Legal

  • Terms
  • Privacy

Copyright © 2026 MolGraph. All Rights Reserved.

Home/Compounds/CAS 138908-40-4
Formula C20H18ClNNa2O7MW 465.8Research-use catalog entryCOA/SDS by request

CL-316243

CAS Number: 138908-40-4

Sourcing & RFQ

Submit an RFQ to review pricing, availability, lead time, pack size, purity, COA, and supplier SDS for this catalog entry.

Supply options

Availability by request

Availability
Available by request
Documents
COA/SDS available on request
Shipping
Shipping reviewed before dispatch

Public pricing is not shown for this CAS. Submit an RFQ to confirm availability, documentation, and shipping review.

Loading RDKit molecule structure...
InChIKey: FUZBPOHHSBDTJQ-CFOQQKEYSA-LC20H18ClNNa2O7 | MW 465.8

Chemical Absolute Identifiers

CAS Number

138908-40-4

PubChem CID

5312115

Molecular Formula

C20H18ClNNa2O7

Molecular Weight

465.8 g/mol

Exact Mass

465.056718

InChIKey

FUZBPOHHSBDTJQ-CFOQQKEYSA-L

IUPAC Name

disodium;5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate

SMILES String

C[C@H](Cc1ccc2c(c1)OC(C(=O)[O-])(C(=O)[O-])O2)NC[C@H](O)c1cccc(Cl)c1.[Na+].[Na+]

Physical Properties

No physical property values available.

Properties are provided as catalog reference data and may be confirmed through supplier documentation when required.

Catalog Facts

Structural features

CL-316243 (CAS 138908-40-4) is listed in the Advanced Chemicals portfolio, with molecular formula C20H18ClNNa2O7 and molecular weight 465. 80 g/mol.

Sourcing context

Catalog reference for RFQ preparation, supplier confirmation, and research chemical sourcing review.

Research use context

Intended for research building-block and synthetic chemistry workflows; structure-derived tags include nitrogen-containing heterocycle.

Documentation needs

COA/SDS status, availability, lead time, pack size, and shipment documentation can be confirmed during quotation.

Applications & Classification

Organic Building BlocksSynthetic ChemistryResearch intermediateCustom synthesis building blockResearch chemical sourcingCustom synthesis and catalog availability reviewCOA, SDS, pricing, and fulfillment workflow
Biological target reference

ChEMBL reports experimental activity evidence for: Beta-3 adrenergic receptor (Rattus norvegicus) — 4 assays; Beta-3 adrenergic receptor (Homo sapiens) — 4 assays. These records describe research assays and do not establish therapeutic efficacy or clinical use.

Beta-3 adrenergic receptor

Rattus norvegicus · SINGLE PROTEIN · 4 qualifying assays · 3 documents · best pChEMBL 8.52

Experimental evidence source: ChEMBL

Beta-3 adrenergic receptor

Homo sapiens · SINGLE PROTEIN · 4 qualifying assays · 3 documents · best pChEMBL 6.66

Experimental evidence source: ChEMBL

Safety & Handling

Safety and handling reference content is available through documentation requests.

For supplier-issued SDS, request documentation before handling, storage, shipment, or procurement decisions.

Preliminary Safety Reference

For supplier-issued SDS or COA, submit a documentation request.

Safety Reference / SDS Request

Names & Synonyms / External Identifiers

Chemical Name

CL-316243

Names & Synonyms

CL 316,243CL 316243CL-316,243Disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylateCL316,243
Show all synonyms
1,3-Benzodioxole-2,2-dicarboxylic acid, 5-[(2R)-2-[[(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]propyl]-, sodium salt (1:2)CL-316243 sodiumCL316243 Disodium SaltDisodium 5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylate138908-40-4 (sodium salt)CL 316243 disodiumC20H18ClNNa2O7CL 316,243 hydrateSodium 5-((R)-2-(((R)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)benzo[d][1,3]dioxole-2,2-dicarboxylateC 59761,3-Benzodioxole-2,2-dicanboxylic acid, 5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)-, disodium salt, (R-(R*,R*))-5-(2-((2-(3-CHLOROPHENYL)-2-HYDROXYETYL)AMINO)-PROPYL)-1,3-BENZODIOXOLE-2,2-DICARBOXYLIC ACID DISODIUM,(R-(R*,R*))5-[(2R)-2-[[(2R)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]propyl]-1,3-benzodioxole-2,2-dicarboxylic acid disodiumDisodium 5-((R)-2-(((R)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)propyl)benzo[d][1,3]dioxole-2,2-dicarboxylate
External Identifiers
DSSTOX SUBSTANCE ID: DTXSID6041004CHEMBL ID: CHEMBL32590UNII: CF9MRO9QWWCL316243DisodiumSalt
Literature & Patent References
DOI 10.1007/s00044-009-9257-xComparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists.PMID 21170122Comparative 3D QSAR study on β(1)-, β(2)-, and β(3)-adrenoceptor agonists.DOI 10.1016/s0960-894x(01)00063-42,4-Thiazolidinediones as potent and selective human beta3 agonists.DOI 10.1016/s0960-894x(01)00628-xBeta 3 agonists. Part 1: evolution from inception to BMS-194449.DOI 10.1021/jm000455zDiscovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.DOI 10.1021/jm000544b(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.PMID 112775132,4-Thiazolidinediones as potent and selective human beta3 agonists.PMID 11311067Discovery of novel N-phenylglycine derivatives as potent and selective beta(3)-adrenoceptor agonists for the treatment of frequent urination and urinary incontinence.

Documentation & Compliance Facts

Compliance Facts

Shipment review: Required

Documentation available by request

Certificate of Analysis (COA): By request

Supplier Safety Data Sheet (SDS): By request

Purity and pack size confirmation: By request

Availability and lead time review: Confirmed by RFQ

Shipment documentation review: By request

For supplier-issued documentation by request, use the RFQ actions on this page.Review preliminary safety reference

What happens after RFQ

  1. 1We review the CAS identity, quantity, and documentation request.
  2. 2We check sourcing options, supplier availability, COA/SDS, purity, pack size, and lead time.
  3. 3We review destination and shipment documentation needs when applicable.
  4. 4We follow up with a quotation or clarification request.

Text Reference Cues

Show non-linked catalog cues

Non-public related references

Sodium 2,6-dichlorobenzoateCAS 10007-84-8
Sodium mandelateCAS 114-21-6
Sodium 2,5-dichlorobenzoateCAS 63891-98-5
Loxoprofen SodiumCAS 80382-23-6
Diclofenac sodiumCAS 15307-79-6

Non-public references are shown as text only and do not imply equivalence, availability, or shared use.

Catalog navigation

Related Catalog Entries

Other public CAS pages in this catalog. These links support navigation across additional intermediates and do not imply equivalence, availability, or shared use.

CAS 1190389-15-1VibegronCAS 159182-43-14-[[(Hexylamino)carbonyl]amino]-N-[4-[2-[[(2S)-2-hydroxy-3-(4-hydroxyphenoxy)propyl]amino]ethyl]phenyl]-benzenesulfonamideCAS 1002310-00-0Tert-butyl 1-(2-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)ethylcarbamateCAS 1005174-17-3(E)-3-(2-Propyl-6-(trifluoromethyl)pyridin-3-yl)acrylic acidCAS 1018125-49-92-(3-Cyclopropyl-6-ethyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acidCAS 1018128-07-8Isopropyl 4-chloro-2-methylquinoline-6-carboxylateCAS 1018142-22-76-cyclopropyl-1-(2,2-difluoroethyl)-3-methyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acidCAS 1018144-00-72-(3-Cyclopropyl-6-isopropyl-4-(trifluoromethyl)-1H-pyrazolo[3,4-b]pyridin-1-yl)acetic acid

RFQ questions for CAS 138908-40-4

What are the key identifiers for CL-316243 (CAS 138908-40-4)?

CL-316243 is identified by CAS 138908-40-4, with molecular formula C20H18ClNNa2O7, molecular weight 465.8, InChIKey FUZBPOHHSBDTJQ-CFOQQKEYSA-L.

Does CAS 138908-40-4 have reported biological target evidence?

ChEMBL contains qualifying experimental assay evidence associated with Beta-3 adrenergic receptor, Beta-3 adrenergic receptor. These records do not establish therapeutic efficacy or clinical use.

Can I request a COA for CAS 138908-40-4?

Yes. Submit an RFQ and specify COA requirements. Lot-specific COA depends on supplier confirmation.

Can I request supplier SDS for CL-316243?

Yes. Supplier SDS can be requested through the RFQ workflow before handling, storage, shipment, or procurement decisions.

Is CAS 138908-40-4 available for quotation?

Availability, pack size, lead time, and pricing are confirmed through RFQ.

Can MolGraph support bulk sourcing or custom synthesis review?

Submit the CAS number, quantity, purity requirement, and destination country for sourcing review.